Tomezzoli, Anna
 Distribuzione geografica
Continente #
NA - Nord America 1.208
EU - Europa 1.013
AS - Asia 387
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 2.612
Nazione #
US - Stati Uniti d'America 1.206
GB - Regno Unito 501
CN - Cina 344
SE - Svezia 109
IE - Irlanda 78
IT - Italia 78
FR - Francia 76
DE - Germania 64
FI - Finlandia 53
BE - Belgio 22
UA - Ucraina 19
KR - Corea 14
TR - Turchia 8
VN - Vietnam 8
RU - Federazione Russa 4
IR - Iran 3
EG - Egitto 2
IN - India 2
JP - Giappone 2
NL - Olanda 2
AM - Armenia 1
AU - Australia 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
HK - Hong Kong 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MX - Messico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 2.612
Città #
Southend 473
Chandler 240
Woodbridge 151
Jacksonville 148
Ann Arbor 131
Houston 87
Dublin 78
Ashburn 59
Beijing 44
Jinan 42
Wilmington 40
Lawrence 32
Princeton 32
Nanjing 31
Shenyang 31
New York 24
Verona 24
Brussels 22
Nanchang 22
Falls Church 17
Haikou 16
Hebei 16
Zhengzhou 16
Ningbo 14
Seoul 13
Tianjin 13
Jiaxing 11
Changsha 9
Milan 9
Sindelfingen 9
Hangzhou 8
Helsinki 8
Los Angeles 8
Taiyuan 8
Taizhou 8
Guangzhou 7
Lanzhou 7
Dong Ket 6
Boardman 5
Norwalk 5
Auburn Hills 4
Fuzhou 4
Redmond 4
Chicago 3
Dearborn 3
Düsseldorf 3
Fairfield 3
Ardabil 2
Cairo 2
Costa Mesa 2
Genoa 2
Kemerovo 2
Leawood 2
Liverpool 2
Lonigo 2
Nürnberg 2
Redwood City 2
Rome 2
Sacramento 2
Venice 2
Almaty 1
Augusta 1
Bangor 1
Bilgi 1
Bishkek 1
Bologna 1
Bratislava 1
Carpi 1
Casoria 1
Charlotte 1
Civitavecchia 1
Colombo 1
Edinburgh 1
Groningen 1
Hollywood 1
Jesi 1
Kharkov 1
Kochi 1
Lancaster 1
Luxembourg 1
Madrid 1
Marco de Canaveses 1
Melbourne 1
Mexico City 1
Napoli 1
Oude Meer 1
Perkasie 1
Pescara 1
Phoenix 1
Riva 1
San Francisco 1
Seattle 1
São Paulo 1
Tallinn 1
Tappahannock 1
Tashkent 1
Toronto 1
Trieste 1
Washington 1
Yerevan 1
Totale 2.014
Nome #
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 152
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 141
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 127
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 126
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 116
Sonographic diagnosis of acute cholecystitis in patients with symptomatic gallstones 110
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker 107
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 102
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 90
Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci 88
Precocious giant pseudoaneurysm of an "innocent" ascending aorta after bicuspid aortic valve replacement redo 87
Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. 84
Endoscopic submucosal dissection in the treatment of gastric submucosal tumors: results from a retrospective cohort study. 81
hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications. 80
Microsatellite instability in gastric cancer is associated with better prognosis only in stage II cancers 73
Influence of Myocardial Fibrosis on Left Ventricular Hypertrophy in Patients with Symptomatic Severe Aortic Stenosis. 73
Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG) 72
Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response: A phase 2 study. 69
MET mutations in cancers of unknown primary origin (CUPs) 67
HERG-1 channel expression in gastric dysplasia 67
Interobserver reproducibility in pathologist interpretation of columnar-lined esophagus 67
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 67
Impact of myocardial fibrosis on left ventricular hypertrophy in symptomatic severe aortic stenosis patients 65
Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. 63
Induction chemo-radiotherapy for squamous cell carcinoma of the thoracic esofagus: impact of increased dosage on long-term results. 61
Risultati preliminari del trattamento neoadiuvante dell’adenocarcinoma del giunto esofago-gastrico. 61
Herg-1 channels and VEGF-A clinical significance in gastric cancer 61
VEGF-A clinical significance in gastric cancers: Immunohistochemical analysis of a wide Italian cohort 60
Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study 60
Gastric Lymphomas 59
The Modern treatment of early gastric cancer: our experience an an Italian cohort 55
TNM classification after neoadjuvant CHT in gastric cancer 42
Totale 2.633
Categoria #
all - tutte 7.157
article - articoli 6.489
book - libri 0
conference - conferenze 668
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201930 0 0 0 0 0 0 0 0 0 0 20 10
2019/2020336 38 6 4 21 32 33 51 25 43 31 16 36
2020/2021297 40 67 11 45 35 20 4 13 15 8 29 10
2021/2022320 21 89 10 27 26 11 11 20 9 9 29 58
2022/2023613 43 79 52 120 55 144 1 36 60 4 15 4
2023/2024218 12 21 21 31 42 49 6 13 0 23 0 0
Totale 2.633